130 related articles for article (PubMed ID: 12432056)
1. Long-term care after hematopoietic-cell transplantation in adults.
Boeckh M; Nichols WG; Marr KA
N Engl J Med; 2002 Nov; 347(20):1625-6; author reply 1625-6. PubMed ID: 12432056
[No Abstract] [Full Text] [Related]
2. Current status and impact of CMV prevention following pediatric organ transplantation.
Allen UD
Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425
[No Abstract] [Full Text] [Related]
3. What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?
Candoni A; Simeone E; Tiribelli M; Pipan C; Fanin R
Bone Marrow Transplant; 2008 Aug; 42(3):207-8. PubMed ID: 18425144
[No Abstract] [Full Text] [Related]
4. Prevention of cytomegalovirus reactivaction after allogenic hematopoietic stem cell transplantation with valganciclovir: single center experience.
Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
J Chemother; 2008 Feb; 20(1):140-2. PubMed ID: 18343759
[No Abstract] [Full Text] [Related]
5. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.
Snydman DR
Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209
[No Abstract] [Full Text] [Related]
6. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
Mwintshi K; Brennan DC
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
Wilkin A; Feinberg J
Oncology (Williston Park); 2000 Dec; 14(12):1701-8; discussion 1708, passim. PubMed ID: 11212856
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
Gondo H
Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
[No Abstract] [Full Text] [Related]
10. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
Safdar A; Rodriguez GH; Mihu CN; Mora-Ramos L; Mulanovich V; Chemaly RF; Champlin RE; Khouri I
Bone Marrow Transplant; 2010 Feb; 45(2):339-47. PubMed ID: 19561648
[TBL] [Abstract][Full Text] [Related]
11. [Valganciclovir. Oral treatment of Cytomegalovirus infections].
Kroes AC
Ned Tijdschr Geneeskd; 2004 Jun; 148(25):1236-8. PubMed ID: 15301386
[TBL] [Abstract][Full Text] [Related]
12. A new step toward individualized antifungal prevention in hematopoietic stem cell transplantation.
Bochud PY; Calandra T
Clin Infect Dis; 2009 Sep; 49(5):733-5. PubMed ID: 19614558
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus in hematopoietic stem cell transplant recipients.
Ljungman P; Hakki M; Boeckh M
Infect Dis Clin North Am; 2010 Jun; 24(2):319-37. PubMed ID: 20466273
[TBL] [Abstract][Full Text] [Related]
14. [Post-transplant infectious diseases].
Mori T
Rinsho Ketsueki; 2014 Oct; 55(10):2136-41. PubMed ID: 25297780
[No Abstract] [Full Text] [Related]
15. [Complications of hematopoietic stem cell transplantation and the treatment: infections].
Ishida Y; Sugawara T
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1344-50. PubMed ID: 16097590
[No Abstract] [Full Text] [Related]
16. [Human cytomegalovirus in hematopoietic stem cell transplantation].
Mori T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():480-4. PubMed ID: 16615519
[No Abstract] [Full Text] [Related]
17. Preemptive therapy for cytomegalovirus.
Singh N; Yu VL
Liver Transpl; 2006 Feb; 12(2):327. PubMed ID: 16447192
[No Abstract] [Full Text] [Related]
18. Cytomegalovirus infection following stem cell transplantation.
Einsele H; Hebart H
Haematologica; 1999 Jun; 84 Suppl EHA-4():46-9. PubMed ID: 10907466
[No Abstract] [Full Text] [Related]
19. [Infections in stem cell transplantation].
Rovira M; Camps IR
Enferm Infecc Microbiol Clin; 2007; 25(7):477-86. PubMed ID: 17692215
[TBL] [Abstract][Full Text] [Related]
20. Infectious disease trends among immunocompromised hosts.
Young B; Tambyah PA
Singapore Med J; 2012 Apr; 53(4):223-9; quiz 230. PubMed ID: 22511041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
